newsfilter
← Latest News
GlobeNewswire·

Histogen Provides Update on its Development Programs and Pipeline Focus

Company to Focus its Regenerative Medicine Technology Platform on Developing Orthopedic Product Candidates HST 003 Trial for Cartilage Regeneration in the Knee Remains On-Track with an Anticipated Phase 1/2 Study Initiation in June 2021 HST 004